Antithrombotic Drugs Market - By Type Of Product (Anticoagulant Drugs, Antiplatelet Drugs, Thrombolytic Drugs), By Application (Blood Clot And Thromboembolic Treatment, Hyperlipidemia Treatment, Prophylactic Treatment, Other Applications), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Retailers, Drug Stores), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $ 4000.00 $3200.00 | Pages : 330 | Published : April 2020 | SKU CODE : o&s120 | Format :

Request Sample

Antithrombotic Drugs Market Definition

The antithrombotic drugs market consists of sales of antithrombotic drugs by entities (organizations, sole traders and partnerships) that manufacture antithrombotic drugs which are used to prevent and treat arterial and venous thrombosis and as well reduce the formation of clots.  The antithrombotic drug industry includes establishments that manufacture anti-thrombotic drugs such as anticoagulant, antiplatelet and thrombolytic drugs.

Antithrombotic Drugs Market Size

The global antithrombotic drugs market reached a value of nearly $35,801.9 million in 2019, having grown at a compound annual growth rate (CAGR) of 9.8% since 2015. Growth in the historic period resulted from aging population and emerging markets.

Growth in the historic period resulted from aging population and emerging markets. Factors that negatively affected growth in the historic period were patent expiry of drugs, pricing, high costs of drug approval. The market is expected to grow at a CAGR of 7.7% to nearly $44,702.6 million by 2022.Also the market is expected to growth to $55,172.2 million in 2025 at a CAGR of 7.3% and to $ 72,996.5 million in 2030 at a CAGR of 5.8%.

Going forward, busy life styles, technology and faster economic growth is expected to drive the market. Factor that could hinder the growth of the antithrombotic drugs market in the future include pricing pressures and side effects of antithrombotic drugs.

Antithrombotic Drugs Market Drivers

The key drivers of the antithrombotic drugs market include:

Aging Populations

The aging population profile of most countries contributed to the growth of the anti-thrombotic drugs market. During 2014-2017 the number of people globally over the age of 65 grew from below 450 million to 601 million, an increase of 33%, according to estimates based on Population Reference Bureau data. This trend is expected to continue throughout the forecast period. The percentage of seniors is expected to grow from 24% in 2012 to 40% in 2050 in Japan.  The increase in the aging population has increased the patient pool of cardiovascular diseases which is a leading cause of premature deaths. In 2013, South Asia, including India, has experienced more than 1.8 million deaths due to cardiovascular diseases. This has led to increased demand for antithrombotic drugs that prevents blood clots or thrombosis and reduces the risk of stroke or heart attack, significantly impacting market growth during this period.  

Antithrombotic Drugs Market Restraints

The key restraints on the antithrombotic drugs market include:

Thrombosis Drugs’ Side Effects

Side effects are the major issue faced by the thrombosis patients and therefore often doctors try to recommend alternate therapy to their patients and this factor is expected to limit the growth of anti-thrombotic drug market in the forecast period. Most of the side effects of the antithrombotic drugs are increased bruising, red or pink colored urine, more bleeding than normal in menstrual periods in females, pain, increased risk of pregnancy complications, and a change in temperature. For example, warfarin can lead to fetal death if a woman is pregnant and consuming the drug.

Antithrombotic Drugs Market Trends

Major trends influencing the antithrombotic drugs market include:

Novel Oral Anti-coagulants (NOACs) To Prevent Thrombosis

NOACs are gaining wider acceptance and are replacing traditionally used anti-coagulants such as Warfarin and Heparin.  Anti-coagulants have long been used in prevention of thrombus formation in patients suffering with cardiovascular diseases. Use of NOACs makes it easier for patients to continue therapy post discharge as opposed to injections of Heparin and Warfarin which need medical assistance for administration. Some of the NOACs include Pradaxa (dabigatran etexilate) from Boehringer Ingelheim, Xarelto (rivaroxaban) from Janssen, and Eliquis (apixaban) from Bristol-Myers Squibb.

Tranexamic Acid To Prevent Postpartum Hemorrhage

Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its cheap price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage.  In April 2017, WOMAN (World Maternal Antifibrinolytic), an international, randomized, double-blind, placebo-controlled trial including over 20,000 women from 193 hospitals in 21 countries, found that using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%, as compared to placebo.  Tranexamic acids are also used in treating bleeding that can be caused by new antithrombotic drugs such as dagibatran, rivaroxaban, and fondaparinux.

Opportunities And Recommendations In The Antithrombotic Drugs Market

Opportunities – The antithrombotic drugs market size will gain the most in China at $2,674.0 million. Market-trend-based strategies for the antithrombotic drugs market include developing effective therapies that replace traditional therapies, developing tranexamic acid drug and new patented drugs to offer improved treatment to thrombosis patients. Player-adopted strategies in the antithrombotic drugs industry include strengthening portfolio through mergers and acquisitions and investing in research and development for development of new drug regimen for thrombotic conditions.

Recommendations – To take advantage of these opportunities, The Business Research Company recommends the antithrombotic drugs companies to focus on Developing Novel Oral Anti-coagulants (NOACs), adopting skimming price strategy, scaling up through collaborations, and using Direct-To-Consumer (DTC) advertising, among other strategies.

Antithrombotic Drugs Market Segmentation

The antithrombotic drugs market is segmented by type, by end-use industry and by geography.
By Type- The antithrombotic drugs market can be segmented by type into
    • a) Anti-Coagulant Drugs
    • b) Anti-Fibrinolytics Drugs
    • c) Anti-Platelet Drugs
The anticoagulant drugs market was the largest segment of the antithrombotic drugs market, accounting for 54.6% of the total market in 2019. The antiplatelet drugs market is expected to be the fastest-growing segment going forward at a CAGR of 8.7%.
By Application- The antithrombotic drugs market can be segmented by application into
    • a) Blood Clot And Thromboembolic Treatment Drugs
    • b) Hyperlipidemia Treatment
    • c) Prophylactic Treatment
    • d) Other Applications
The blood clot and thromboembolic treatment drugs was the largest and fastest growing segment of the antithrombotic drugs market by application, accounting for 35.9% of the total market in 2019. By Drug Class - The antithrombotic drugs market can be segmented by drug class into
    • a) Heparin
    • b) Apixaban
    • c) Rivaroxaban
    • d) Others
    • e) Dabigatran
    • f) Fondaparinux
The heparin was the largest segment of the antithrombotic drugs market by drug class, accounting for 38.6% of the total market in 2019. The apixaban market is expected to be the fastest-growing segment going forward at a CAGR of 12.5%.
By Route Of Administration- The antithrombotic drugs market can be segmented by route of administration into
    • a) Oral
    • b) Parenteral Route
The oral was largest segment of the antithrombotic drugs market, accounting for 70.8% of the total market in 2019, and is expected to be the fastest-growing segment going forward at a CAGR of 8.2%.
By Distribution Channel- The antithrombotic drugs market can be segmented by distribution channel into
    • a) General Pharmacies
    • b) Hospital Pharmacies
    • c) Online Retailers
The general pharmacies was largest segment of the antithrombotic drugs market, accounting for 62.2% of the total market in 2019. The online retailers’ distribution channel is expected to be the fastest-growing segment going forward at a CAGR of 13.0%.
By Geography- The antithrombotic drugs market is segmented into
    • o North America
      • USA
    • o Western Europe
      • UK
      • Germany
      • France
    • o Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • Indonesia
      • South Korea
    • o Eastern Europe
      • Russia
    • o South America
      • Brazil
    • o Middle East
    • o Africa
Asia-Pacific was the largest region in the antithrombotic drugs market, accounting for 36.1% of the global market in 2019. It was followed by North America, Western Europe and the other regions. Going forward, the fastest growing regions in the antithrombotic drugs market will be Asia-Pacific and the Middle East

Antithrombotic Drugs Competitive Landscape

Major Competitors are:
    • • Bristol Myers Squibb
    • • Bayer AG
    • • Pfizer
    • • Johnson & Johnson
    • • Boehringer-Ingelheim
Other Competitors Include:
    • • AstraZeneca
    • • Daichii Sankyo
    • • Eli Lilly
    • • Otsuka Pharmaceutical
    • • Portola Pharmaceutical Inc.
    • • Yuyu Pharma Inc.
    • • Daiichi Sankyo Company, Limited
    • • Glenmark Pharmaceuticals Limited
    • • China National Pharmaceutical Group Corp
    • • Novartis
    • • Acetlion Pharmaceuticals
    • • Generium
    • • Aspen
    • • Servier
    • • Sun Pharmaceutical Industries Ltd
    • • Petrovax LLC
    • • Janssen Pharmaceuticals
    • • Merck & Co
    • • Servier Canada Inc
    • • Valeo Pharma
    • • JP Indústria Pharmaceutica SA
    • • Cristália
    • • Julphar
    • • SAJA Pharmaceuticals
    • • Saudi Pharmaceutical Industries & Medical Appliances Corporation

  1. 1. Antithrombotic Drugs Market Executive Summary
  2. 2. Table of Contents
  3. 3. List of Figures
  4. 4. List of Tables
  5. 5. Report Structure
  6. 6. Antithrombotic Drugs Market Characteristics
    • 6.1. Market Segmentation By Type Of Product
      • 6.1.1. Anticoagulant Drugs
      • 6.1.2. Antiplatelet Drugs
      • 6.1.3. Thrombolytic Drugs
    • 6.2. Market Segmentation By Application
      • 6.2.1. Blood Clot And Thromboembolic Treatment
      • 6.2.2. Hyperlipidemia Treatment
      • 6.2.3. Prophylactic Treatment
      • 6.2.4. Other Applications
    • 6.3. Market Segmentation By Class
      • 6.3.1. Fondaparinux
      • 6.3.2. Heparin
      • 6.3.3. Apixaban
      • 6.3.4. Dabigatran
      • 6.3.5. Rivaroxaban
      • 6.3.6. Others
    • 6.4. Market Segmentation By Route Of Administration
      • 6.4.1. Oral
      • 6.4.2. Parenteral
    • 6.5. Market Segmentation By Distribution Channel
      • 6.5.1. Hospital Pharmacies
      • 6.5.2. Online Retailers
      • 6.5.3. Drug Stores
  7. 7. Global Antithrombotic Drugs Market Size And Growth
    • 7.1. Historic And Forecast Market Growth, Value ($ Million)
      • 7.1.1. Historic Drivers Of The Market 2015-2019
      • 7.1.2. Historic Restraints Of The Market 2015-2019
      • 7.1.3. Forecast Drivers Of The Market 2019-2022
      • 7.1.4. Forecast Restraints Of The Market 2019-2022
  8. 8. Global Antithrombotic Drugs Market Segmentation
    • 8.1. Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 8.2. Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 8.3. Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 8.4. Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 8.5. Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  9. 9. Antithrombotic Drugs Market, Regional And Country Analysis
    • 9.1. Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 9.2. Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  10. 10. Asia-Pacific Antithrombotic Drugs Market
    • 10.1.Asia-Pacific Antithrombotic Drugs Market Overview
      • 10.1.1. Region Information
      • 10.1.2. Market Information
      • 10.1.3. Background Information
      • 10.1.4. New Drug Approvals
      • 10.1.5. Government Initiatives
      • 10.1.6. Regulatory Bodies
      • 10.1.7. Regulations
      • 10.1.8. Associations
      • 10.1.9. Taxes Levied
      • 10.1.10. Corporate Tax
      • 10.1.11. Investments
      • 10.1.12. Major Companies
    • 10.2.Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 10.3.Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.4.Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.5.Asia-Pacific Antithrombotic Drugs Market: Country Analysis
    • 10.6.China Antithrombotic Drugs Market
    • 10.7.China Antithrombotic Drugs Market Overview
      • 10.7.1. Country Information
      • 10.7.2. Market Information
      • 10.7.3. Background Information
      • 10.7.4. New Drug Approvals
      • 10.7.5. Government Initiatives
      • 10.7.6. Regulatory Bodies
      • 10.7.7. Regulations
      • 10.7.8. Associations
      • 10.7.9. Taxes Levied
      • 10.7.10. Corporate Tax
      • 10.7.11. Investments
      • 10.7.12. Major Companies
    • 10.8.China Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 10.9.China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.10. China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.11. India Antithrombotic Drugs Market
    • 10.12. India Antithrombotic Drugs Market Overview
      • 10.12.1. Country Information
      • 10.12.2. Market Information
      • 10.12.3. Background Information
      • 10.12.4. New Drug Approvals
      • 10.12.5. Government Initiatives
      • 10.12.6. Regulatory Bodies
      • 10.12.7. Regulations
      • 10.12.8. Associations
      • 10.12.9. Taxes Levied
      • 10.12.10. Corporate Tax
      • 10.12.11. Investments
      • 10.12.12. Major Companies
    • 10.13. India Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 10.14. India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.15. India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.16. Japan Antithrombotic Drugs Market
    • 10.17. Japan Antithrombotic Drugs Market Overview
      • 10.17.1. Region Information
      • 10.17.2. Market Information
      • 10.17.3. Background Information
      • 10.17.4. Government Initiatives
      • 10.17.5. Regulatory Bodies
      • 10.17.6. Regulations
      • 10.17.7. Associations
      • 10.17.8. Taxes Levied
      • 10.17.9. Corporate Tax
      • 10.17.10. Investments
      • 10.17.11. Major Companies
    • 10.18. Japan Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 10.19. Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.20. Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.21. Australia Antithrombotic Drugs Market
    • 10.22. Australia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 10.23. Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.24. Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.25. Indonesia Antithrombotic Drugs Market
    • 10.26. Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 10.27. Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.28. Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.29. South Korea Antithrombotic Drugs Market
    • 10.30. South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 10.31. South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 10.32. South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  11. 11. Western Europe Antithrombotic Drugs Market
    • 11.1.Western Europe Antithrombotic Drugs Market Overview
      • 11.1.1. Region Information
      • 11.1.2. Market Information
      • 11.1.3. Background Information
      • 11.1.4. New Drug Approvals
      • 11.1.5. Government Initiatives
      • 11.1.6. Regulatory Bodies
      • 11.1.7. Regulations
      • 11.1.8. Associations
      • 11.1.9. Taxes Levied
      • 11.1.10. Corporate Tax
      • 11.1.11. Investments
      • 11.1.12. Major Companies
    • 11.2.Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 11.3.Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 11.4.Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 11.5.Western Europe Antithrombotic Drugs Market: Country Analysis
    • 11.6.UK Antithrombotic Drugs Market
    • 11.7.UK Antithrombotic Drugs Market Overview
      • 11.7.1. Region Information
      • 11.7.2. Market Information
      • 11.7.3. Background Information
      • 11.7.4. New Drug Approvals
      • 11.7.5. Government Initiatives
      • 11.7.6. Regulatory Bodies
      • 11.7.7. Regulations
      • 11.7.8. Associations
      • 11.7.9. Taxes Levied
      • 11.7.10. Corporate Tax
      • 11.7.11. Investments
      • 11.7.12. Major Companies
    • 11.8.UK Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 11.9.UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 11.10. UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 11.11. Germany Antithrombotic Drugs Market
    • 11.12. Germany Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 11.13. Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 11.14. Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 11.15. France Antithrombotic Drugs Market
    • 11.16. France Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 11.17. France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 11.18. France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  12. 12. Eastern Europe Antithrombotic Drugs Market
    • 12.1.Eastern Europe Antithrombotic Drugs Market Overview
      • 12.1.1. Region Information
      • 12.1.2. Market Information
      • 12.1.3. Background Information
      • 12.1.4. New Drug Approvals
      • 12.1.5. Government Initiatives
      • 12.1.6. Regulatory Bodies
      • 12.1.7. Regulations
      • 12.1.8. Associations
      • 12.1.9. Taxes Levied
      • 12.1.10. Corporate Tax
      • 12.1.11. Investments
      • 12.1.12. Major Companies
    • 12.2.Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 12.3.Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 12.4.Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 12.5.Eastern Europe Antithrombotic Drugs Market: Country Analysis
    • 12.6.Russia Antithrombotic Drugs Market
    • 12.7.Russia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 12.8.Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 12.9.Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  13. 13. North America Antithrombotic Drugs Market
    • 13.1.North America Antithrombotic Drugs Market Overview
      • 13.1.1. Region Information
      • 13.1.2. Market Information
      • 13.1.3. Background Information
      • 13.1.4. New Drug Approvals
      • 13.1.5. Government Initiatives
      • 13.1.6. Regulatory Bodies
      • 13.1.7. Regulations
      • 13.1.8. Associations
      • 13.1.9. Taxes Levied
      • 13.1.10. Corporate Tax
      • 13.1.11. Investments
      • 13.1.12. Major Companies
    • 13.2.North America Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 13.3.North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 13.4.North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 13.5.North America Antithrombotic Drugs Market: Country Analysis
    • 13.6.USA Antithrombotic Drugs Market
    • 13.7.USA Antithrombotic Drugs Market Overview
      • 13.7.1. Country Information
      • 13.7.2. Market Information
      • 13.7.3. Background Information
      • 13.7.4. New Drug Approvals
      • 13.7.5. Government Initiatives
      • 13.7.6. Regulatory Bodies
      • 13.7.7. Regulations
      • 13.7.8. Associations
      • 13.7.9. Taxes Levied
      • 13.7.10. Corporate Tax
      • 13.7.11. Investments
      • 13.7.12. Major Companies
    • 13.8.USA Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 13.9.USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 13.10. USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  14. 14. South America Antithrombotic Drugs Market
    • 14.1.South America Antithrombotic Drugs Market Overview
      • 14.1.1. Region Information
      • 14.1.2. Market Information
      • 14.1.3. Background Information
      • 14.1.4. Government Initiatives
      • 14.1.5. Regulatory Bodies
      • 14.1.6. Regulations
      • 14.1.7. Associations
      • 14.1.8. Taxes Levied
      • 14.1.9. Corporate Tax
      • 14.1.10. Major Companies
    • 14.2.South America Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 14.3.South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 14.4.South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 14.5.South America Antithrombotic Drugs Market: Country Analysis
    • 14.6.Brazil Antithrombotic Drugs Market
    • 14.7.Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 14.8.Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 14.9.Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  15. 15. Middle East Antithrombotic Drugs Market
    • 15.1.Middle East Antithrombotic Drugs Market Overview
      • 15.1.1. Region Information
      • 15.1.2. Market Information
      • 15.1.3. Government Initiatives
      • 15.1.4. Regulatory Bodies
      • 15.1.5. Regulations
      • 15.1.6. Associations
      • 15.1.7. Taxes Levied
      • 15.1.8. Corporate Tax
      • 15.1.9. Investments
      • 15.1.10. Major Companies
    • 15.2.Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 15.3.Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 15.4.Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  16. 16. Africa Antithrombotic Drugs Market
    • 16.1.Africa Antithrombotic Drugs Market Overview
      • 16.1.1. Region Information
      • 16.1.2. Market Information
      • 16.1.3. Government Initiatives
      • 16.1.4. Regulatory Bodies
      • 16.1.5. Regulations
      • 16.1.6. Associations
      • 16.1.7. Taxes Levied
      • 16.1.8. Corporate Tax
      • 16.1.9. Major Companies
    • 16.2.Africa Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
    • 16.3.Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
    • 16.4.Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, Value ($ Million)
  17. 17. Global Antithrombotic Drugs Market Competitive Landscape
    • 17.1.Company Profiles
    • 17.2.Bristol Myers Squibb
      • 17.2.1. Company Overview
      • 17.2.2. Products And Services
      • 17.2.3. Business Strategy
      • 17.2.4. Financial Overview
    • 17.3.Bayer AG
      • 17.3.1. Company Overview
      • 17.3.2. Products And Services
      • 17.3.3. Business Strategy
      • 17.3.4. Financial Overview
    • 17.4.Pfizer
      • 17.4.1. Company Overview
      • 17.4.2. Products And Services
      • 17.4.3. Business Strategy
      • 17.4.4. Financial Overview
    • 17.5.Johnson & Johnson
      • 17.5.1. Company Overview
      • 17.5.2. Products And Services
      • 17.5.3. Business Strategy
      • 17.5.4. Financial Overview
    • 17.6.Boehringer-Ingelheim GmbH
      • 17.6.1. Company Overview
      • 17.6.2. Products And Services
      • 17.6.3. Business Strategy
      • 17.6.4. Financial Overview
  18. 18. Key Mergers And Acquisitions In The Antithrombotic Drugs Market
    • 18.1.AMAG Pharmaceuticals Acquired Perosphere Pharmaceuticals
    • 18.2.Johnson & Johnson Acquired Bristol-Myers Cardiovascular Disease Program
    • 18.3.Sanofi Acquired Bioverativ Inc.
    • 18.4.AstraZeneca Acquired Antithrombotic Candidate From APT Therapeutics
    • 18.5.Bristol-Myers Acquired Cardioxyl`s Heart Failure Therapy
    • 18.6.Janssen Acquired XO1 Limited
  19. 19. Antithrombotic Drugs Market Trends And Strategies
    • 19.1.Novel Oral Anti-coagulants(NOACs) To Prevent Thrombosis
    • 19.2.Tranexamic Acid To Prevent Postpartum Hemorrhage
    • 19.3.New Antithrombotic Biologics To Cure Blood Vessel Wall Injury
  20. 20. Antithrombotic Drugs Market, Product Pipeline Analysis
  21. 21. Antithrombotic Drugs Market Future Outlook and Potential Analysis
    • 21.1.Global Antithrombotic Drugs Market In 2022 – Countries Offering Most New Opportunities
    • 21.2.Global Antithrombotic Drugs Market In 2022- Segments Offering Most New Opportunities
    • 21.3.Global Antithrombotic Drugs Market In 2022 – Growth Strategies
      • 21.3.1. Market Trend Based Strategies
      • 21.3.2. Competitor Strategies
  22. 22. AntithromboticDrugs Market, Conclusions And Recommendations
    • 22.1.Conclusions
    • 22.2.Recommendations
      • 22.2.1. Product
      • 22.2.2. Price
      • 22.2.3. Place
      • 22.2.4. Promotion
  23. 23. Appendix
    • 23.1.Market Data Sources
    • 23.2.Research Methodology
    • 23.3.Currencies
    • 23.4.Research Inquiries
    • 23.5.The Business Research Company
  24. 24. Copyright and Disclaimer

List Of Tables

    Table 1: Global Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 2: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 3: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 4: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 5: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 6: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 7: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 8: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 9: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 10: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 11: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 12: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 13: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 14: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 15: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 16: Asia-Pacific, Prevalence Of Rheumatic Heart Disease, 2014-2017
  • Table 17: Asia-Pacific, Ischemic Heart Disease, 2014-2017
  • Table 18: Asia-Pacific, Prevalence Of Ischemic Stroke, 2014-2017
  • Table 19: Asia-Pacific, Intracerebral Hemorrhage, 2014-2017
  • Table 20: Asia-Pacific, Prevalence Of Subarachnoid Hemorrhage, 2014-2017
  • Table 21: Asia-Pacific, Prevalence Of Non-Rheumatic Calcific Aortic Valve Disease, 2014-2017
  • Table 22: Asia-Pacific, Prevalence Of Myocarditis, 2014-2017
  • Table 23: Asia-Pacific, Prevalence Of Rheumatic Heart Disease, 2014-2017
  • Table 24: Asia-Pacific, Prevalence Of Other Cardiovascular And Circulatory Diseases, 2014-2017
  • Table 25: Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 26: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 27: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 28: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 29: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 30: China, Prevalence Of Thrombotic Conditions, 2014-2017
  • Table 31: China Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 32: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 33: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 34: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 35: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 36: India, Prevalence Of Thrombotic Conditions, 2014-2017
  • Table 37: India Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 38: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 39: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 40: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 41: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 42: Japan, Prevalence Of Thrombotic Conditions, 2014-2017
  • Table 43: Japan Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 44: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 45: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 46: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 47: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 48: Australia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 49: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 50: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 51: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 52: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 53: Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 54: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 55: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 56: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 57: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 58: South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 59: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 60: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 61: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 62: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 63: Western Europe, Prevalence Of Rheumatic Heart Disease, 2014-2017
  • Table 64: Western Europe, Ischemic Heart Disease, 2014-2017
  • Table 65: Western Europe, Prevalence Of Ischemic Stroke, 2014-2017
  • Table 66: Western Europe, Intracerebral Hemorrhage, 2014-2017
  • Table 67: Western Europe, Prevalence Of Subarachnoid Hemorrhage, 2014-2017
  • Table 68: Western Europe, Prevalence Of Non-Rheumatic Calcific Aortic Valve Disease, 2014-2017
  • Table 69: Western Europe, Prevalence Of Myocarditis, 2014-2017
  • Table 70: Western Europe, Prevalence Of Rheumatic Heart Disease, 2014-2017
  • Table 71: Western Europe, Prevalence Of Other Cardiovascular And Circulatory Diseases, 2014-2017
  • Table 72: Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 73: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 74: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 75: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 76: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 77: UK, Prevalence Of Thrombotic Conditions, 2014-2017
  • Table 78: UK Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 79: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 80: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 81: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 82: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 83: Germany Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 84: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 85: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 86: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 87: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 88: France Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 89: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 90: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 91: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 92: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 93: Russia, Prevalence Of Thrombotic Conditions, 2014-2017
  • Table 94: Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 95: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 96: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 97: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 98: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 99: Russia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 100: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 101: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 102: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 103: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 104: USA, Prevalence Of Thrombotic Conditions, 2014-2017
  • Table 105: North America Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 106: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 107: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 108: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 109: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 110: USA, Prevalence Of Thrombotic Conditions, 2014-2017
  • Table 111: USA Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 112: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 113: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 114: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 115: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 116: Brazil, Prevalence Of Thrombotic Conditions, 2014-2017
  • Table 117: South America Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 118: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 119: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 120: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 121: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 122: Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 123: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 124: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 125: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 126: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 127: Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 128: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 129: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 130: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 131: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 132: Africa Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Table 133: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 134: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 135: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Table 136: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Million
  • Table 137: Global Antithrombotic Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)
  • Table 138: Bristol Myers Squibb – Financial Performance, 2015-2019, $ Billion
  • Table 139: Bayer AG –  Financial Performance, 2015-2019, $ Billion
  • Table 140: Pfizer– Financial Performance, 2015-2019, $ Billion
  • Table 141: Johnson & Johnson (J&J)– Financial Performance, 2014 - 2018, $ Billion
  • Table 142: Boehringer Ingelheim GmbH – Financial Performance, $ Billion
  • Table 143: Global Antithrombotic Drugs Market, Product Pipeline Analysis
  • Table 144: Antithrombotic Drugs Market Size Gain ($ Million), 2019 – 2022, By Country
  • Table 145: Antithrombotic Drugs Market Size Gain ($ Million), 2019 – 2022, By Type
  • Table 146: Antithrombotic Drugs Market Size Gain ($ Million), 2019 – 2022, By Application Type
  • Table 147: Antithrombotic Drugs Market Data Sources

List Of Figures

    Figure 1: Global Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 2: Global Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 3: Global Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 4: Global Antithrombotic Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 5: Global Antithrombotic Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 6: Global Antithrombotic Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 7: Global Antithrombotic Drugs Market, By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 8: Global Antithrombotic Drugs Market, By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 9: Asia-Pacific Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 10: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 11: Asia-Pacific Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 12: China Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 13: China Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 14: China Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 15: India Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 16: India Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 17: India Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 18: Japan Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 19: Japan Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 20: Japan Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 21: Australia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 22: Australia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 23: Australia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 24: Indonesia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 25: Indonesia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 26: Indonesia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 27: South Korea Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 28: South Korea Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 29: South Korea Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 30: Western Europe Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 31: Western Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 32: Western Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 33: UK Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 34: UK Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 35: UK Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 36: Germany Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 37: Germany Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 38: Germany Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 39: France Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 40: France Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 41: France Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 42: Eastern Europe Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 43: Eastern Europe Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 44: Eastern Europe Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 45: Russia Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 46: Russia Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 47: Russia Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 48: North America Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 49: North America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 50: North America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 51: USA Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 52: USA Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 53: USA Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 54: South America Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 55: South America Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 56: South America Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 57: Brazil Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 58: Brazil Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 59: Brazil Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 60: Middle East Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 61: Middle East Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 62: Middle East Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 63: Africa Antithrombotic Drugs Market, Historic And Forecast, 2015 – 2019, 2022F, 2025F, 2030F, $ Million
  • Figure 64: Africa Antithrombotic Drugs Market, Segmentation By Type, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 65: Africa Antithrombotic Drugs Market, Segmentation By Application, Historic And Forecast, 2015-2019, 2022F, 2025F, 2030F, %
  • Figure 66: Global Antithrombotic Drugs Market, Key Competitor Estimated Market Shares, 2018, Percentage (%)
  • Figure 67: Bristol Myers Squibb – Financial Performance, 2015-2019, $ Billion
  • Figure 68: Bayer AG – Financial Performance, 2015-2019, $ Billion
  • Figure 69: Pfizer– Financial Performance, 2015-2019, $ Billion
  • Figure 70: Johnson & Johnson (J&J)– Financial Performance, 2014 - 2018,$ Billion
  • Figure 71: Boehringer Ingelheim GmbH – Financial Performance, $ Billion
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)